The second wave of desaturation in coronavirus disease 2019.

Alghizzawi, M I; Ata, F; Yousaf, Z; Alhiyari, M A; Bint I Bilal, A; Elhiday, A; Abdulhadi, A S

Alghizzawi, M I; Ata, F; Yousaf, Z; Alhiyari, M A; Bint I Bilal, A; Elhiday, A; Abdulhadi, A S.

Alghizzawi MI; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Ata F; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Yousaf Z; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Alhiyari MA; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Bint I Bilal A; Department of Radiology, Hamad Medical Corporation, Doha, Qatar.
Elhiday A; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Abdulhadi AS; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

New Microbes New Infect ; 41: 100866, 2021 May.

Article in English | MEDLINE | ID: covidwho-1179930

ABSTRACT

ABSTRACT

After a complete symptomatic recovery from coronavirus disease 2019 pneumonia, the second phase of desaturation is a new phenomenon that is being increasingly observed. Two possible mechanisms behind it can be a continued subclinical infection and lung fibrosis. We have presented a case with the former mechanism, who responded well to steroids.

Keywords

Coronavirus disease 2019; desaturation; dyspnoea; fibrosis; severe acute respiratory syndrome coronavirus 2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: New Microbes New Infect Year: 2021 Document Type: Article Affiliation country: J.nmni.2021.100866

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google